News
This regulatory approval is the second for VYVGART SC in Europe, which first received approval as an add-on to standard therapy for the treatment of adult patients with generalized myasthenia gravis ...
SE (NASDAQ:ARGX) said on Friday that it has received approval from the European Commission for its IgG Fc-antibody fragment, ...
15hon MSN
The recent death of a British woman from rabies after a holiday in Morocco is a sobering reminder of the risks posed by this ...
Alberta's measles outbreaks have led to babies being born with congenital measles, the province has confirmed. Congenital ...
The recent death of a British woman from rabies is a sobering reminder of the risks posed by the fatal disease ...
During a live event, Taewoong Choi, MD, discussed the potential use of quadruplet in transplant-ineligible multiple myeloma ...
The death of a British woman after a dog bite abroad has sparked widespread concern. What do we all need to know?
Bali warns of an increased risk of rabies. This is a reminder of the risks of a disease that is almost universally fatal if ...
The Global Albumin Market is expected to grow at a rate of 6% by 2026. The development of albumin-based nanoparticles for drug delivery, high demand for albumin in R&D activities & clinical trials, ...
10h
Stocktwits on MSNArgenx Gets European Commission Approval For Drug To Treat Rare Autoimmune Disease, But Stock Fails To Garner Retail AttentionNasdaq-listed shares of argenx SE (ARGX) rose 2% by Friday afternoon after the company announced that the European Commission ...
New research has uncovered why humans consistently develop IgG antibodies to peanut proteins, regardless of whether they have a peanut allergy. The study found that human antibody genes predispose ...
Objective This study aims to evaluate the role of antiphospholipid antibodies (aPLs) in patients with SLE with heart valve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results